Rilzabrutinib is a reversible covalent BTK inhibitor. Also
known as Wayrilz, PRN1008. ApiSyn undertakes custom synthesis and process
development for complex molecules of this type, and any supply is subject to
patent/licensing review; no availability is implied.
| Chemical Name | (R,E)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile |
| Molecular Formula | C36H40FN9O3 |
| Molecular Weight | 665.8 |
| CAS Number | 1575596-29-0 |